Cedars Health
About Cedars Health
Cedars Health is developing a minimally invasive implant to surgically address benign prostatic hyperplasia (BPH). BPH is a noncancerous prostate enlargement that obstructs the urinary channel, causes urinary problems, and decreases the quality of life for 35 million men in the US and 500 million men worldwide. They are developing a cost-effective BPH treatment option that is without complications to make it more available and accessible for the patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Total funding: $50.0K
- Funding stage: Seed
- Last round: Grant (Oct 2021)
Industries & Categories
Health Care, Medical, Wellness
Canonical: https://fsome.com/organization/cedars-health-2228678 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.